featured
Any Regression of Tumor (ART) as a Potential Intermediate Endpoint in Patients With Solid Tumors Receiving ICIs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: